Monthly Archives: May 2004

AURORA, CO, May 25, 2004 – GlobeImmune, Inc. today announced that the Company’s Investigational New Drug (IND) application for the GI-4000 product series, filed with the U.S. Food & Drug Administration last month, has become effective after the initial 30-day … Continue reading →

AURORA, CO, May 13, 2004 – GlobeImmune, Inc. today announced that Teresa Brentnall, MD, Edgar Engleman, MD, Edward Mocarski, PhD, Alan Venook, MD, and Bruce Walker, MD have been appointed to the company’s Scientific Advisory Board. “These outstanding professionals in … Continue reading →